Beranda › Tumor Neuroendokrin › Illinois › Chicago
Uji klinis Tumor Neuroendokrin di Chicago, IL
7 studi untuk Tumor Neuroendokrin mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Menerima pesertaFase 3
- Investigative Site, Chicago
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- University of Illinois, Chicago
- dan 1 lainnya
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Menerima pesertaFase 1/2
- University of Chicago, Chicago
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Menerima pesertaFase 1/2
- The University of Chicago, Chicago
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Menerima pesertaFase 1/2
- University of Chicago, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Menerima pesertaFase 4
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chicago
Uji klinis Tumor Neuroendokrin di kota lain
- Washington, DC11 studi
- Philadelphia, PA11 studi
- Rochester, MN9 studi
- Columbus, OH8 studi
- St. Louis, MO8 studi
- Houston, TX8 studi
- Salt Lake City, UT8 studi
- Cleveland, OH7 studi
- New York City, NY7 studi
- Cedar Rapids, IA7 studi
- Miami, FL7 studi
- Detroit, MI7 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Obesitas41 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal33 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.